Frequency of Positive ANCA Test in a Population With Clinical Symptoms Suggestive of Autoimmune Disease and the Interference of ANA in its Interpretation;
Autores organización
Autores
- Benavides-Solarte M
- Galindo-Ibáñez I
- Ospina-Caicedo AI
- Villa A
- Casas-Gómez MC
- Angarita I
- Romero-Álvarez V
- Bello-Gualtero JM
Grupos de investigación
Resumen
Background: Antibodies against neutrophil cytoplasm (ANCA) are associated with vasculitis. There are different methods to determine their presence. The interference of antinuclear antibodies (ANA) in the differentiation between P-ANCA and C-ANCA patterns has been described. Objective: To determine the frequency of ANCA in a population with manifestations of autoimmune disease, and evaluate the interference of ANA in its interpretation. Materials and methods: Retrospective, descriptive nonexperimental cross-sectional study, including 3,330 data. The presumptive diagnosis was autoimmune disease and a test for ANCA was requested. The ANCA and ANA determinations were made by indirect immunofluorescence, L-ANCA® and CytoBead® ANCA. Anti-proteinase 3 and anti-myeloperoxidase were detected by ELISA and CytoBead® ANCA. Results: ANCAs were positive in 10.21% and 12.64% of those positive for ANCA were positive for ANA. The inter-rater agreement statistic (Kappa) for anti-PR3 between CytoBead ANCA and ELISA was 100% (K = 1.00; P <.05) and the agreement between anti- myeloperoxidase by ELISA and CytoBead® ANCA was high (K = 0.94; P <.05). 30% of those with ANCAs had a diagnosis of a type of vasculitis; 20% of them had an autoimmune disease. Conclusions: The results suggest an overestimated request for ANCAs as a diagnostic aid in primary care which was not addressed. For an adequate evaluation of ANCAs, the indirect immunofluorescence technique should be implemented for the control and confirmation with the determination of specific antigens for anti- proteinase 3 and anti- myeloperoxidase in any of the confirmatory assays. The high concordance shown by ANCA CytoBeads makes us consider the use of this alternative for the determination of ANCAs and the confirmation. Given the interference of ANAs, the ANA test by IFI in the presence of positive P-ANCA results is recommended in order to minimize “false positives”. © 2018 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología
Copyright © 2018 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 1699-258X, 1885-1398
- Tipo:
- Article
- Páginas:
- 473-479
- Enlace a otro recurso:
- www.scopus.com
Reumatologia Clinica Ediciones Doyma, S.L.
Citas Recibidas en Web of Science: 5
Citas Recibidas en Scopus: 8
Documentos
- No hay documentos
Filiaciones
Keywords
- Adult; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Antinuclear; Autoimmune Diseases; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Retrospective Studies; Vasculitis; Young Adult; antinuclear antibody; myeloblastin; myeloperoxidase; neutrophil cytoplasmic antibody; antinuclear antibody; neutrophil cytoplasmic antibody; Article; autoimmune disease; clinical feature; cross-sectional study; descriptive research; disease association; enzyme linked immunosorbent assay; false positive result; human; immunofluorescence test; retrospective study; adult; autoimmune disease; blood; female; immunology; male; middle aged; vasculitis; young adult
Proyectos asociados
Cambios en la mucosa colónica y oral y su asociación con manifestaciones clínicas y con los niveles de SIgA: Un estudio transversal en pacientes con espondiloartritis con síntomas y/o anticuerpos asociados a trastornos gastrointestinales
Investigador Principal: MARIA CONSUELO ROMERO SANCHEZ
UEB-2017-436 . 2018
Citar la publicación
Romero C,Benavides M,Galindo I,Ospina AI,Parra V,Chila L,Villa A,Casas MC,Angarita I,Bautista W,Romero V,Bello JM. Frequency of Positive ANCA Test in a Population With Clinical Symptoms Suggestive of Autoimmune Disease and the Interference of ANA in its Interpretation;. Reumatol Clin (Engl Ed). 2020. 16. (6):p. 473-479.